TELA Bio
TELA
45 hedge funds and large institutions have $165M invested in TELA Bio in 2021 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 12 closing their positions.
12% more capital invested
Capital invested by funds: $147M → $165M (+$17.4M)
2.41% more ownership
Funds ownership: 68.5% → 70.91% (+2.4%)
7% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 14
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 47 → 45 (-2)
17% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 12
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PVI
Pura Vida Investments
New York
|
+$4.61M |
| 2 |
GPCM
Granite Point Capital Management
Boston,
Massachusetts
|
+$2.74M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
+$2.19M |
| 4 |
PHP
Parkman Healthcare Partners
Stamford,
Connecticut
|
+$1.37M |
| 5 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.03M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
-$3.98M |
| 2 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.5M |
| 3 |
State Street
Boston,
Massachusetts
|
-$1.16M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$1.06M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$851K |
TELA Hedge Fund Activity: Q2 2021 in Review
45 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q2 2021, worth a combined $165M — up 12% from $147M a quarter earlier.
Sellers outnumbered buyers: 12 funds closed out of TELA and 10 opened new positions — a net loss of 2 holders — while 14 trimmed existing stakes and 15 added.
The largest buyer was Pura Vida Investments, adding an estimated $4.61M. The largest seller was BlackRock, cutting an estimated $3.98M.
- 45 institutional investors held TELA Bio (TELA) as of Q2 2021, down from 47 in Q1 2021.
- Funds reported $165M of TELA Bio stock for Q2 2021, up 12% quarter-over-quarter.
- 10 funds opened new TELA Bio positions in Q2 2021 and 12 closed out, a net change of -2 holders.
- The largest TELA Bio buyer in Q2 2021 was Pura Vida Investments, an estimated $4.61M added.
- The largest TELA Bio seller in Q2 2021 was BlackRock, an estimated $3.98M sold.
Based on aggregated 13F filings for Q2 2021.